Loading clinical trials...
Loading clinical trials...
Treatment Outcomes and Plasma Level of Ritonavir-boosted Lopinavir Monotherapy Among HIV-infected Patients Who Had Non-nucleoside Reverse Transcriptase Inhibitor (NRTI) and NNRTI Failure: A Pilot Study
Conditions
Interventions
lopinavir/ritonavir soft gel capsule
Locations
1
Thailand
Bamrasnaradura Infectious Diseases Institute
Nonthaburi, Changwat Nonthaburi, Thailand
Start Date
April 1, 2007
Primary Completion Date
February 1, 2011
Completion Date
February 1, 2011
Last Updated
November 11, 2011
NCT01875588
NCT04929028
NCT07071623
NCT07199335
NCT03087253
NCT05419024
Lead Sponsor
Bamrasnaradura Infectious Diseases Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions